Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2380 (LINC02380)

Target
LINC02380
Molecular classification
Long non-coding RNA, Long intergenic non-coding RNA (lincRNA)
01

Overview

LINC02380 encodes a long intergenic non-coding RNA transcript that does not overlap protein-coding genes and is presumed to regulate gene expression at different cellular levels, including transcription and chromatin remodeling. Dysregulation of lincRNAs such as LINC02380 is implicated in carcinogenesis and other diseases, with increasing interest in their utility as biomarkers and therapeutic targets. The specific biological function of LINC02380 remains to be fully elucidated, but evidence suggests altered expression in lung cancer, offering potential in tumor discrimination and diagnosis. Long intergenic non-coding RNAs typically demonstrate tissue- and development-specific expression patterns, participating in regulatory processes without encoding proteins.

02

Mechanism of action

For lncRNAs in general: modulation of gene expression, epigenetic regulation, interference with transcription factor activity

03

Biological functions

Gene regulation at multiple levels (transcriptional, post-transcriptional, chromatin remodeling)Possible roles in cell proliferation, apoptosis, and differentiation, as with other lincRNAsMay function in *cis* or *trans* acting mechanisms
04

Disease associations

Potential biomarker for cancer, including lung cancerDysregulation implicated in various diseases (general to lncRNAs): cancer, cardiovascular disease, neurodegenerative disease, autoimmune diseaseLINC02380 identified among lncRNAs with altered expression in lung cancer datasets, suggesting a role in tumorigenesis and as a diagnostic biomarker
05

Safety considerations

Therapeutic targeting of lncRNAs presents challenges such as tissue specificity, lack of protein products, and risk of off-target effects
06

Biomarkers

LINC02380 and similar lncRNAs are studied as diagnostic biomarkers, especially in lung cancer

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2380 (LINC02380).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2380 (LINC02380).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call